Moreover, strong CD4+ T cell responses have been associated with better clinical outcomes in COVID-19 patients, while reduced levels of CD4+ T cells correlated with higher rates of breakthrough infections or more severe disease [35]. The gene discussed is CD4; the disease is COVID-19.